ℹ️
🇬🇧
Search
Search for people relevant for "Optimalization"
Optimalization
Person
Class
Person
Publication
Programmes
Export current view
prof. MUDr. Tomáš Büchler Ph.D.
Academic staff at Second Faculty of Medicine
5 classes
291 publications
Classes
class
Oncology
+1
D0110016 |
Second Faculty of Medicine
class
Nursing Care of patients in oncology and paliative care
+1
D0905005 |
Second Faculty of Medicine
class
OS
DV01191 |
Second Faculty of Medicine
Publications
publication
Elevated cardiac markers are associated with higher mortality in patients after transjugular intrahepatic portosystemic shunt insertion
2013 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Current Applications of Cardiac Troponin T for the Diagnosis of Myocardial Damage
2013 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Another approach to targeted therapy of patients with metastatic renal carcinoma with progression in treatment with pazopanib:expert assessment by the Czech Cooperative Group for Metastatic Renal Carcinoma
2013 |
First Faculty of Medicine
publication
Renal cell carcinoma – overview of treatment of advanced and metastatic disease
2013 |
First Faculty of Medicine
publication
Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinoma
2012 |
First Faculty of Medicine
publication
A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma
2012 |
First Faculty of Medicine
publication
Drug interactions of bisphosphonates used in oncology
2010 |
First Faculty of Medicine
publication
Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinoma
2024 |
Faculty of Physical Education and Sport, First Faculty of Medicine, Second Faculty of Medicine
publication
Sperm mitochondria dysfunction in response to testicular cancer
2024 |
First Faculty of Medicine, Faculty of Science
publication
Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy
2024 |
Publication without faculty affiliation
Load more publications (281)
Loading network view...